Formycon and Fresenius Kabi announce MHRA approval for FYB202/Otulfi® (ustekinumab), a biosimilar to Stelara® Otulfi ® received MHRA approval for both subcutaneous and intravenous formulations, to ...

Regulatory ApprovalFormycon and Fresenius Kabi announce MHRA approval for FYB202/Otulfi® (ustekinumab), a biosimilar to Stelara® 15.01.2025 / 06:30 CET/CESTThe issuer is solely responsible for the ...

Regulatory ApprovalFormycon and Fresenius Kabi Canada receive Health Canada’s approval for FYB202/Otulfi® (ustekinumab), a biosimilar to Stelara® 08.01.2025 / 14:30 CET/CESTThe issuer is solely ...

Formycon and Fresenius Kabi Canada receive Health Canada’s approval for FYB202/Otulfi® (ustekinumab), a biosimilar to Stelara® Otulfi ® approved by Health Canada for both subcutaneous and intravenous ...

In genetic studies, the term concordance refers to the degree of similarity in a set of twins regarding the presence or absence of a disease or trait. The concordance rate for psoriatic arthritis (30% ...

coli, after 3 months of storage at 4 degrees, in mixed marinated seafood salad containing common octopus (Octopus vulgaris), shrimp (Parapenaeus ... R.H.S.F., Souza, O.V. and Patel, T.R. (1997) ...

Wild edible Swiss chard leaves (Beta vulgaris L. var. cicla): Nutritional ... 2018.25200.6238 Ambhore J, Adhao V, Rafique S, et al. A concise review: Edible mushroom and their medicinal significance.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

StockNews.com assumed coverage on shares of Cutera (NASDAQ:CUTR – Free Report) in a research note issued to investors on Sunday morning. The firm issued a sell rating on the medical device company’s ...